The biocompatibility, stability and reproducibility of this novel method allows its industrial production for uses such as personalized therapy. The Nanomedicine Group of the Marqués de Valdecilla Health Research Institute (IDIVAL) has designed and optimized a novel method based on nanoparticles capable of encapsulating, storing and transferring genetic material into cells. The procedure is easily […]
The 13th Quality and Patient Safety Conference will be held in Santander on 3 and 4 May 2023. An open and participative discussion forum in which the patient safety culture is promoted and good practices carried out in healthcare centres are shared. These conferences have been held for many years in Cantabria and have been […]
This Thursday, 16 March, the conference “Advances in digital transformation: incorporating the use of data into healthcare” will take place at the Marqués de Valdecilla University Hospital. The conference, focused on the opportunities of the use of Big Data and its applicability in healthcare environments, is organised by the IDIVAL Research Institute and sponsored by […]
The 8th March we will have the presentations of Javier Isaac Lera Torres and Rebeca Abajas Bustillo, within the Progress Reports Valdecilla programme. The session will be held in the Innovation and User Experience Laboratory – Linnux at 14:00 hours, and will be broadcast live on the Zoom platform. HEALTH TECHNOLOGY ASSESSMENT (HTA) FROM A […]
On 14, 15 and 16 March the 4th edition of the course “Update in neurology. Neurology in Primary Care” directed by Manuel Delgado Alvarado and Javier Riancho Zarrabeitia, neurologists at Sierrallana Hospital. During the course the main neurological problems will be reviewed with a practical approach. Course limited to 25 places, last places available. Registration […]
Researchers from the IDIVAL neurodegenerative diseases group and the Movement Disorders Unit of the Marqués de Valdecilla University Hospital (HUMV) have participated in a recent study, promoted by the Clínic Barcelona-IDIBAPS, which has detected alterations in the expression profile of four microRNAs, which could make it possible to detect the onset of genetic Parkinson’s disease […]
Care4Diabetes aims to empower patients to take an active role in the management of their disease. Endocrinologist Luis Alberto Vazquez Salví took part in the project’s inaugural conference held on 16 and 17 February in Oviedo with all the partners involved in Care4Diabetes. The aim is to implement in the European Union the Reverse Diabetes2 […]
The second of the modules of the International Forum on Precision Medicine will begin on 28 February, focusing on clinical genomics. The forum is fully supported by the ITEMAS platform and the Biobanks and Biomodels platform of the Carlos III Health Institute and the Spanish Society of Clinical Pharmacology. This course aims to address genomics […]
Additive manufacturing, also known as 3D printing, is a disruptive technology with a promising potential in the health sector. The technology has not yet been fully integrated in hospitals and the health care sector. There are different reasons for this. Some of the barriers are the lack of knowledge and skills on the use […]
From a motor point of view, Parkinson's disease has traditionally been classified into different clinical phenotypes, which may be associated with a different prognosis of the disease. Tremor-predominant subtypes have been associated with more favourable prognoses than non-tremor subtypes. IDIVAL's neurodegenerative diseases group has been participating in the COPPADIS study since 2016. This […]
